Pulmonary Endothelium and Nitric Oxide

The Pulmonary Endothelium: Function in health and disease

Volumn , Issue , 2009, Pages 89-104

  Su, Yunchao ^a   Block, Edward R ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Endothelial L Arginine availability in NO production; ENOS association with cytoskeleton and cellular proteins; ENOS in lung endothelial NO signaling; Lung endothelial NO signaling arginase; Nitric oxide (NO) potent signaling molecule; NO in chronic obstructive pulmonary diseases; NO in leukocyte and platelet endothelium interactions; NO in pulmonary vascular tone regulation; Pulmonary endothelium and nitric oxide

Indexed keywords

EID: 84889270949     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470747490.ch6     Document Type: Chapter

References (126)

1. Moncada, S., Palmer, R.M., and Higgs, E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews, 43, 109-42.
2. Palmer, R.M., Ashton, D.S., and Moncada, S. (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664-66.
3. Luhrs, H., Papadopoulos, T., Schmidt, H.H., and Menzel, T. (2002) Type I nitric oxide synthase in the human lung is predominantly expressed in capillary endothelial cells. Respiration Physiology, 129, 367-74.
4. Zulueta, J.J., Sawhney, R., Kayyali, U. et al. (2002) Modulation of inducible nitric oxide synthase by hypoxia in pulmonary artery endothelial cells. American Journal of Respiratory Cell and Molecular Biology, 26, 22-30.
5. Palmer, L.A., Semenza, G.L., Stoler, M.H., and Johns, R.A. (1998) Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. American Journal of Physiology: Lung Cellular and Molecular Physiology, 274, L212-19.
6. Fagan, K.A., Tyler, R.C., Sato, K. et al. (1999) Relative contributions of endothelial, inducible, and neuronal NOS to tone in the murine pulmonary circulation. American Journal of Physiology: Lung Cellular and Molecular Physiology, 277, L472-78.
7. Block, E.R., Herrera, H., and Couch, M. (1995) Hypoxia inhibits L-arginine uptake by pulmonary artery endothelial cells. American Journal ofPhys-iology: Lung Cellular and Molecular Physiology, 269, L574-80.
8. McDonald, K.K., Zharikov, S., Block, E.R., and Kilberg, M.S. (1997) A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox". The Journal of Biological Chemistry, 272, 31213-16.
9. Su, Y. and Block, E.R. (1995) Hypoxia inhibits L-arginine synthesis from L-citrulline in porcine pulmonary artery endothelial cells. American Journal of Physiology: Lung Cellular and Molecular Physiology, 269, L581-87.
10. Stamler, J.S., Loh, E., Roddy, M.A. et al. (1994) Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation, 89, 2035-40.
11. Fagan, K.A., McMurtry, I., and Rodman, D.M. (2000) Nitric oxide synthase in pulmonary hypertension: lessons from knockout mice. Physiological Research, 49, 539-48.
12. Vaughan, D.J., Brogan, T.V., Kerr, M.E. et al. (2003) Contributions of nitric oxide synthase isozymes to exhaled nitric oxide and hypoxic pulmonary vasoconstriction in rabbit lungs. American Journal of Physiology: Lung Cellular and Molecular Physiology, 284, L834-43.
13. Cremona, G., Wood, A.M., Hall, L.W. et al. (1994) Effect of inhibitors of nitric oxide release and action on vascular tone in isolated lungs of pig, sheep, dog and man. The Journal of Physiology, 481, 185-95.
14. Steudel, W., Ichinose, F., Huang, P.L. et al. (1997) Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circulation Research, 81, 34-41.
15. Jiang, L., Quarck, R., Janssens, S. et al. (2006) Effect of adenovirus-mediated gene transfer of nitric oxide synthase on vascular reactivity of rat isolated pulmonary arteries. Pflugers Archiv, 452, 213-21.
16. Champion, H.C., Bivalacqua, T.J., D'Souza, F.M. et al. (1999) Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo. Effect on agonist-induced and flow-mediated vascular responses. Circulation Research, 84, 1422-32.
17. Champion, H.C., Bivalacqua, T.J., Greenberg, S.S. et al. (2002) Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 99, 13248-53.
18. Frostell, C., Fratacci, M.D., Wain, J.C. et al. (1991) Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation, 83, 2038-47.
19. Ichinose, F., Roberts, J.D. Jr., and Zapol, W.M. (2004) Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation, 109, 3106-11.
20. Han, R.N. and Stewart, D.J. (2006) Defective lung vascular development in endothelial nitric oxide synthase-deficient mice. Trends in Cardiovascular Medicine, 16, 29-34.
21. Han, R.N., Babaei, S., Robb, M. et al. (2004) Defective lung vascular development and fatal respiratory distress in endothelial NO synthase-deficient mice: a model of alveolar capillary dysplasia? Circulation Research, 94, 1115-23.
22. Balasubramaniam, V., Tang, J.R., Maxey, A. et al. (2003) Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. American Journal of Physiology: Lung Cellular and Molecular Physiology, 284, L964-71.
23. Leuwerke, S.M., Kaza, A.K., Tribble, C.G. et al. (2002) Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. American Journal of Physiology: Lung Cellular and Molecular Physiology, 282, L1272-78.
24. Balasubramaniam, V., Maxey, A.M., Morgan, D.B. et al. (2006) Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia. American Journal of Physiology: Lung Cellular and Molecular Physiology, 291, L119-27.
25. Lin, Y.J., Markham, N.E., Balasubramaniam, V. et al. (2005) Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatric Research, 58, 22-29.
26. Tang, J.R., Markham, N.E., Lin, Y.J. et al. (2004) Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. American Journal of Physiology: Lung Cellular and Molecular Physiology, 287, L344-51.
27. Stenmark, K.R. and Abman, S.H. (2005) Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annual Review of Physiology, 67, 623-61.
28. Hood, J.D., Meininger, C.J., Ziche, M., and Granger, H.J. (1998) VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. American Journal of Physiology: Heart and Circulatory Physiology, 274, H1054-58.
29. Chen, Y., Medhora, M., Falck, J.R. et al. (2006) Mechanisms of activation of eNOS by 20-HETE and VEGF in bovine pulmonary artery endothelial cells. American Journal of Physiology: Lung Cellular and Molecular Physiology, 291, L378-85.
30. Kaminski, A., Pohl, C.B., Sponholz, C. et al. (2004) Up-regulation of endothelial nitric oxide synthase inhibits pulmonary leukocyte migration following lung ischemia-reperfusion in mice. American Journal of Pathology, 164, 2241-49.
31. Hickey, M.J. and Kubes, P. (1997) Role of nitric oxide in regulation of leucocyte-endothelial cell interactions. Experimental Physiology, 82, 339-48.
32. Kubes, P., Suzuki, M., and Granger, D.N. (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proceedings of the National Academy of Sciences of the United States of America, 88, 4651-55.
33. Lefer, D.J., Jones, S.P., Girod, W.G. et al. (1999) Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. American Journal of Physiology: Heart and Circulatory Physiology, 276, H1943-50.
34. de Graaf, J.C., Banga, J.D., Moncada, S. et al. (1992) Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation, 85, 2284-90.
35. Radomski, M.W., Palmer, R.M., and Moncada, S. (1987) The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochemical and Biophysical Research Communications, 148, 1482-89.
36. Payen, D.M. (2000) Inhaled nitric oxide and acute lung injury. Clinics in Chest Medicine, 21, 519-29, ix.
37. Gaston, B., Singel, D., Doctor, A., and Stam-ler, J.S. (2006) S-nitrosothiol signaling in respiratory biology. American Journal of Respiratory and Critical Care Medicine, 173, 1186-93.
38. McMahon, T.J., Ahearn, G.S., Moya, M.P. et al. (2005) A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. Proceedings of the National Academy of Sciences of the United States of America, 102, 14801-6.
39. Moya, M.P., Gow, A.J., McMahon, T.J. et al. (2001) S-Nitrosothiol repletion by an inhaled gas regulates pulmonary function. Proceedings of the National Academy of Sciences of the United States of America, 98, 5792-97.
40. McMahon, T.J., Exton, S.A., Bonaventura, J. et al. (2000) Functional coupling of oxygen binding and vasoactivity in S-nitrosohemoglobin. The Journal of Biological Chemistry, 275, 16738-45.
41. McMahon, T.J., Moon, R.E., Luschinger, B.P. et al. (2002) Nitric oxide in the human respiratory cycle. Nature Medicine, 8, 711-17.
42. Gow, A.J. and Stamler, J.S. (1998) Reactions between nitric oxide and haemoglobin under physiological conditions. Nature, 391, 169-73.
43. Coggins, M.P. and Bloch, K.D. (2007) Nitric oxide in the pulmonary vasculature. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 1877-85.
44. Aisaka, K., Gross, S.S., Griffith, O.W., and Levi, R. (1989) L-Arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo. Biochemical and Biophysical Research Communications, 163, 710-17.
45. Eddahibi, S., Adnot, S., Carville, C. et al. (1992) L-Arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. American Journal of Physiology: Lung Cellular and Molecular Physiology, 263, L194-200.
46. Closs, E.I., Scheld, J.S., Sharafi, M., and Forster-mann, U. (2000) Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Molecular Pharmacology, 57, 68-74.
47. Simon, A., Plies, L., Habermeier, A. et al. (2003) Role of neutral amino acid transport and protein breakdown for substrate supply of nitric oxide synthase in human endothelial cells. Circulation Research, 93, 813-20.
48. Wu, G. and Morris, S.M. Jr. (1998) Arginine metabolism: nitric oxide and beyond. The Biochemical Journal, 336, 1-17.
49. Hallemeesch, M.M., Lamers, W.H., and Deutz, N.E. (2002) Reduced arginine availability and nitric oxide production. Clinical Nutrition, 21, 273-79.
50. Morris, S.M. Jr. (2005) Arginine metabolism in vascular biology and disease. Vascular Medicine, 10 (Suppl 1), S83-S87.
51. Deves, R. and Boyd, C.A. (1998) Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiological Reviews, 78, 487-545.
52. Zharikov, S.I. and Block, E.R. (1998) Characterization of L-arginine uptake by plasma membrane vesicles isolated from cultured pulmonary artery endothelial cells. Biochimica et Biophysica Acta, 1369, 173-83.
53. Closs, E.I., Boissel, J.P., Habermeier, A., and Rot-mann, A. (2006) Structure and function of cationic amino acid transporters (CATs). The Journal of Membrane Biology, 213, 67-77.
54. Hammermann, R., Brunn, G., and Racke, K. (2001) Analysis of the genomic organization of the human cationic amino acid transporters CAT-1, CAT-2 and CAT-4. Amino Acids, 21, 211-19.
55. Hatzoglou, M., Fernandez, J., Yaman, I., and Closs, E. (2004) Regulation of cationic amino acid transport: the story of the CAT-1 transporter. Annual Review of Nutrition, 24, 377-99.
56. Krotova, K.Y., Zharikov, S.I., and Block, E.R. (2003) Classical isoforms of PKC as regulators of CAT-1 transporter activity in pulmonary artery endothelial cells. American Journal ofPhysiology: Lung Cellular and Molecular Physiology, 284, L1037-44.
57. Zharikov, S.I., Herrera, H., and Block, E.R. (1997) Role of membrane potential in hypoxic inhibition of L-arginine uptake by lung endothelial cells. American Journal of Physiology: Lung Cellular and Molecular Physiology, 272, L78-84.
58. Zharikov, S.I., Krotova, K.Y., Belayev, L., and Block, E.R. (2004) Pertussis toxin activates L-arginine uptake in pulmonary endothelial cells through downregulation of PKC-alpha activity. American Journal of Physiology: Lung Cellular and Molecular Physiology, 286, L974-83.
59. Flam, B.R., Hartmann, P.J., Harrell-Booth, M. et al. (2001) Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase. Nitric Oxide, 5, 187-97.
60. Reiter, C.D., Wang, X., Tanus-Santos, J.E. et al. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 1383-89.
61. Sessa, W.C., Hecker, M., Mitchell, J.A., and Vane, J.R. (1990) The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: L-glutamine inhibits the generation of L-arginine by cultured endothelial cells. Proceedings of the National Academy of Sciences of the United States of America, 87, 8607-11.
62. Su, Y. and Block, E.R. (1997) Hypoxia inhibits the induction of argininosuccinate synthetase by endotoxin in lung endothelial cells. American Journal ofPhysiology: Lung Cellular and Molecular Physiology, 272, L934-38.
63. Flam, B.R., Eichler, D.C., and Solomonson, L.P. (2007) Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric Oxide, 17, 115-21.
64. Arnal, J.F., Munzel, T., Venema, R.C. et al. (1995) Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. The Journal of Clinical Investigation, 95, 2565-72.
65. Solomonson, L.P., Flam, B.R., Pendleton, L.C. et al. (2003) The caveolar nitric oxide synthase/arginine regeneration system for NO production in endothelial cells. The Journal of Experimental Biology, 206, 2083-87.
66. Durante, W., Johnson, F.K., and Johnson, R.A. (2007) Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clinical and Experimental Pharmacology and Physiology, 34, 906-11.
67. Nelin, L.D., Nash, H.E., and Chicoine, L.G. (2001) Cytokine treatment increases arginine metabolism and uptake in bovine pulmonary arterial endothelial cells. American Journal of Physiology: Lung Cellular and Molecular Physiology, 281, L1232-39.
68. Kawamoto, S., Amaya, Y., Murakami, K. et al. (1987) Complete nucleotide sequence of cDNA and deduced amino acid sequence of rat liver arginase. The Journal of Biological Chemistry, 262, 6280-83.
69. Topal, G., Brunet, A., Walch, L. et al. (2006) Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells. The Journal of Pharmacology and Experimental Therapeutics, 318, 1368-74.
70. Chicoine, L.G., Paffett, M.L., Young, T.L., and Nelin, L.D. (2004) Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. American Journal of Physiology: Lung Cellular and Molecular Physiology, 287, L60-68.
71. Li, H., Meininger, C.J., Hawker, J.R. Jr. et al. (2001) Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. American Journal ofPhysiology: Endocrinology and Metabolism, 280, E75-82.
72. Zhang, C., Hein, T.W., Wang, W. et al. (2001) Constitutive expression of arginase in mi-crovascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. The FASEB Journal, 15, 1264-66.
73. Xu, W., Kaneko, F.T., Zheng, S. et al. (2004) Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. The FASEB Journal, 18, 1746-48.
74. Searles, C.D. (2006) Transcriptional and posttran-scriptional regulation of endothelial nitric oxide synthase expression. American Journal of Physiology: Cell Physiology, 291, C803-16.
75. Li, H., Wallerath, T., and Forstermann, U. (2002) Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide, 7, 132-47.
76. Chan, Y., Fish, J.E., D'Abreo, C. et al. (2004) The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation. The Journal of Biological Chemistry, 279, 35087-100.
77. Fish, J.E., Matouk, C.C., Rachlis, A. et al. (2005) The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. The Journal of Biological Chemistry, 280, 24824-38.
78. MacRitchie, A.N., Jun, S.S., Chen, Z. et al. (1997) Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circulation Research, 81, 355-62.
79. Davis, M.E., Grumbach, I.M., Fukai, T. et al. (2004) Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappaB binding. The Journal of Biological Chemistry, 279, 163-68.
80. Su, Y., Kondrikov, D., and Block, E.R. (2007) β-Actin: a regulator of NOS-3. Science STKE, 2007, e52-1-e52-3.
81. Ou, H., Shen, Y.H., Utama, B. et al. (2005) Effect of nuclear actin on endothelial nitric oxide synthase expression. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 2509-14.
82. Kondrikov, D., Han, H.R., Block, E.R., and Su, Y. (2006) Growth and density-dependent regulation of NO synthase by the actin cytoskeleton in pulmonary artery endothelial cells. American Journal of Physiology: Lung Cellular and Molecular Physiology, 290, L41-50.
83. Bouloumie, A., Schini-Kerth, V.B., and Busse, R. (1999) Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovascular Research, 41, 773-80.
84. Laufs, U., Endres, M., Stagliano, N. et al. (2000) Neuroprotection mediated by changes in the endothelial actin cytoskeleton. The Journal of Clinical Investigation, 106, 15-24.
85. Takemoto, M., Sun, J., Hiroki, J. et al. (2002) Rho-kinase mediates hypoxia-induced downregu-lation of endothelial nitric oxide synthase. Circulation, 106, 57-62.
86. Su, Y., Edwards-Bennett, S., Bubb, M.R., and Block, E.R. (2003) Regulation of endothelial nitric oxide synthase by the actin cytoskeleton. American Journal of Physiology: Cell Physiology, 284, C1542-49.
87. Searles, C.D., Ide, L., Davis, M.E. et al. (2004) Actin cytoskeleton organization and posttranscrip-tional regulation of endothelial nitric oxide synthase during cell growth. Circulation Research, 95, 488-95.
88. Kone, B.C. (2000) Protein-protein interactions controlling nitric oxide synthases. Acta Physiolog-ica Scandinavica, 168, 27-31.
89. Govers, R. and Rabelink, T.J. (2001) Cellular regulation of endothelial nitric oxide synthase. American Journal ofPhysiology: Renal Physiology, 280, F193-206.
90. Dudzinski, D.M. and Michel, T. (2007) Life history of eNOS: partners and pathways. Cardiovascular Research, 75, 247-60.
91. Feron, O., Saldana, F., Michel, J.B., and Michel, T. (1998) The endothelial nitric-oxide synthase-caveolin regulatory cycle. The Journal of Biological Chemistry, 273, 3125-28.
92. Ju, H., Venema, V.J., Marrero, M.B., and Venema, R.C. (1998) Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric-oxide synthase. The Journal of Biological Chemistry, 273, 24025-29.
93. Harris, M.B., Ju, H., Venema, V.J. et al. (2000) Role of heat shock protein 90 in bradykinin-stimulated endothelial nitric oxide release. General Pharmacology, 35, 165-70.
94. Garcia-Cardena, G., Fan, R., Shah, V. et al. (1998) Dynamic activation of endothelial nitric oxide synthase by HSP90. Nature, 392, 821-24.
95. Fontana, J., Fulton, D., Chen, Y. et al. (2002) Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circulation Research, 90, 866-73.
96. Cao, S., Yao, J., and Shah, V. (2003) The proline-rich domain of dynamin-2 is responsible for dynamin-dependent in vitro potentiation of endothelial nitric-oxide synthase activity via selective effects on reductase domain function. The Journal of Biological Chemistry, 278, 5894-901.
97. Su, Y., Zharikov, S.I., and Block, E.R. (2002) Microtubule-active agents modify nitric oxide production in pulmonary artery endothelial cells. American Journal of Physiology: Lung Cellular and Molecular Physiology, 282, L1183-89.
98. Su, Y., Kondrikov, D., and Block, E.R. (2005) Cytoskeletal regulation of nitric oxide synthase. Cell Biochemistry and Biophysics, 43, 439-50.
99. Ravi, K., Brennan, L.A., Levic, S. et al. (2004) S-Nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proceedings of the National Academy of Sciences of the United States of America, 101, 2619-24.
100. Erwin, P.A., Lin, A.J., Golan, D.E., and Michel, T. (2005) Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. The Journal of Biological Chemistry, 280, 19888-94.
101. Moncada, S. and Higgs, A. (1993) The L-arginine-nitric oxide pathway. The New England Journal of Medicine, 329, 2002-12.
102. Xia, Y. (2007) Superoxide generation from nitric oxide synthases. Antioxidants and Redox Signalling, 9, 1773-78.
103. Andriambeloson, E. and Witting, P.K. (2002) Chemical regulation of nitric oxide: a role for in tracellular myoglobin? Redox Report, 7, 131-36.
104. Rayner, B.S., Wu, B.J., Raftery, M. et al. (2005) Human S-nitroso oxymyoglobin is a store of va soactive nitric oxide. The Journal of Biological Chemistry, 280, 9985-93.
105. Ozaki, M., Kawashima, S., Yamashita, T. et al. (2001) Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium. Hypertension, 37, 322-27.
106. Le Cras, T.D. and McMurtry, I.F. (2001) Nitric oxide production in the hypoxic lung. American Journal of Physiology: Lung Cellular and Molecular Physiology, 280, L575-82.
107. Zharikov, S.I. and Block, E.R. (2000) Association of L-arginine transporters with fodrin: implications for hypoxic inhibition of arginine uptake. American Journal of Physiology: Lung Cellular and Molecular Physiology, 278, L111-17.
108. Rengasamy, A. and Johns, R.A. (1996) Determination of Km for oxygen of nitric oxide synthase isoforms. The Journal of Pharmacology and Experimental Therapeutics, 276, 30-33.
109. Liao, J.K., Zulueta, J.J., Yu, F.S. et al. (1995) Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. The Journal of Clinical Investigation, 96, 2661-66.
110. Fike, C.D., Kaplowitz, M.R., Thomas, C.J., and Nelin, L.D. (1998) Chronic hypoxia decreases nitric oxide production and endothelial nitric oxide synthase in newborn pig lungs. American Journal of Physiology: Lung Cellular and Molecular Physiology, 274, L517-26.
111. Xu, X.P., Pollock, J.S., Tanner, M.A., and Myers, P.R. (1995) Hypoxia activates nitric oxide synthase and stimulates nitric oxide production in porcine coronary resistance arteriolar endothelial cells. Cardiovascular Research, 30, 841-47.
112. Arnet, U.A., McMillan, A., Dinerman, J.L. et al. (1996) Regulation of endothelial nitric-oxide synthase during hypoxia. The Journal of Biological Chemistry, 271, 15069-73.
113. Su, Y. and Block, E.R. (2000) Role of calpain in hypoxic inhibition of nitric oxide synthase activity in pulmonary endothelial cells. American Journal of Physiology: Lung Cellular and Molecular Physiology, 278, L1204-12.
114. Murata, T., Sato, K., Hori, M. et al. (2002) Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension. The Journal of Biological Chemistry, 277, 44085-92.
115. phox). American Journal of Physiology: Lung Cellular and Molecular Physiology, 290, L2-10.
116. Kato, G.J., Onyekwere, O.C., and Gladwin, M.T. (2007) Pulmonary hypertension in sickle cell disease: relevance to children. Pediatric Hematology and Oncology, 24, 159-70.
117. Morris, C.R., Kato, G.J., Poljakovic, M. et al. (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. The Journal of the American Medical Association, 294, 81-90.
118. Hsu, L.L., Champion, H.C., Campbell-Lee, S.A. et al. (2007) Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood, 109, 3088-98.
119. Pritchard, K.A. Jr., Ou, J., Ou, Z. et al. (2004) Hypoxia-induced acute lung injury in murine models of sickle cell disease. American Journal of Physiology: Lung Cellular and Molecular Physiology, 286, L705-14.
120. 1-antitrypsin deficiency. American Journal of Respiratory Cell and Molecular Biology, 20, 441-47.
121. Barbera, J.A., Peinado, V.I., Santos, S. et al. (2001) Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. American Journal ofRespiratory and Critical Care Medicine, 164, 709-13.
122. Lee, J.H., Lee, D.S., Kim, E.K. et al. (2005) Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. American Journal ofRespiratory and Critical Care Medicine, 172, 987-93.
123. Su, Y., Han, W., Giraldo, C. et al. (1998) Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. American Journal of Respiratory Cell and Molecular Biology, 19, 819-25.
124. Lowe, E.R., Everett, A.C., Lee, A.J. et al. (2005) Time-dependent inhibition and tetrahy-drobiopterin depletion of endothelial nitric-oxide synthase caused by cigarettes. Drug Metabolism and Disposition, 33, 131-38.
125. Clini, E., Cremona, G., Campana, M. et al. (2000) Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale. Correlates with echo-Doppler assessment. American Journal of Respiratory and Critical Care Medicine, 162, 446-50.
126. Balasubramaniam, V., Tang, J.R., Maxey, A. et al. (2003) Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase (eNOS) deficient mouse. American Journal of Physiology: Lung Cellular and Molecular Physiology, 284, L964-71.